Sequenom shares fall on Down syndrome test patent row; Breast size genetic markers predict breast cancer risk;

> Sequenom shares fall as a U.S. District Court decides against blocking a competitor's Down syndrome marker blood test. Article

> Epigenetic osteoarthritis markers could point to new drugs. Press release | Abstract

> Japanese researchers have suggested that C-reactive protein (CRP) could be used as a prognostic marker in patients with advanced renal cell carcinoma (RCC) treated with sunitinib. Article

> Oxford University researchers have identified 20 novel fibrosis biomarker candidates that may help to assess hepatic fibrosis and eliminate the need for invasive liver biopsies. Abstract | Blog post

> Diagnostics company Saladax Biomedical has extended the availability of its MyCare blood tests to optimize dosing of cancer drugs. Press release

> University of Buffalo researchers are hunting for urine biomarkers for autism. Press release

> Cardiac biomarker troponin T predicts death up to a month after surgery. Press release | Abstract

> Genisphere and the Lankenau Institute for Medical Research have extended their microRNA (miRNA) biomarker development collaboration to include Crohn's disease and other inflammatory bowel disorders. Press release

> TNF levels could link treatment response and inflammation in bipolar disorder. Article

> HPV infection markers have a new role in head and neck cancer. Press release | Abstract

> A fragment of titin, a muscle-specific protein, could be a biomarker for heart damage. Abstract

And Finally… Breast size genetic markers predict breast cancer risk, according to 23andMe. Press release | Abstract

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.